5-hydroxypropafenone has been researched along with dextrorphan in 1 studies
Studies (5-hydroxypropafenone) | Trials (5-hydroxypropafenone) | Recent Studies (post-2010) (5-hydroxypropafenone) | Studies (dextrorphan) | Trials (dextrorphan) | Recent Studies (post-2010) (dextrorphan) |
---|---|---|---|---|---|
59 | 3 | 3 | 456 | 45 | 55 |
Protein | Taxonomy | 5-hydroxypropafenone (IC50) | dextrorphan (IC50) |
---|---|---|---|
Solute carrier family 22 member 1 | Homo sapiens (human) | 6 | |
Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.773 | |
Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 1.3 | |
Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.246 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chow, MS; Fan, C; Lau, CP; Tang, MO; White, CM | 1 |
1 other study(ies) available for 5-hydroxypropafenone and dextrorphan
Article | Year |
---|---|
Evaluation of CYP2D6 oxidation of dextromethorphan and propafenone in a Chinese population with atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; China; Cytochrome P-450 CYP2D6; Dextromethorphan; Dextrorphan; Excitatory Amino Acid Antagonists; Female; Hong Kong; Humans; Male; Middle Aged; Oxidation-Reduction; Propafenone | 2001 |